Stereotactic body radiotherapy (SBRT) for patients with metastatic cancer, especially when
characterised by a low tumour burden (ie, oligometastatic disease), receiving targeted …

Radiation therapy (RT) plays a key role in curative-intent treatments for head and neck
cancers. Its use is indicated as a sole therapy in early stage tumors or in combination with …

Background and purpose Both stereotactic radiotherapy (SRT) and immune-or targeted
therapy play an increasingly important role in personalized treatment of metastatic disease …

Purpose Reirradiation of head and neck (H&N) cancer is a clinical challenge. Proton
radiation therapy (PRT) offers dosimetric advantages for normal tissue sparing and may …

Purpose Salvage options for unresectable locally recurrent, previously irradiated squamous
cell carcinoma of the head and neck (rSCCHN) are limited. Although the addition of …

Purpose To review our 15-year institutional experience using intensity modulated radiation
therapy (IMRT) to reirradiate patients with head and neck squamous cell carcinomas …

Purpose Hypofractionated radiation therapy (hRT) combined with immune checkpoint
blockade can induce T-cell–mediated local and abscopal antitumor effects. We had …

Retreatment of recurrent or second primary head and neck cancers occurring in a previously
irradiated field is complex. Few guidelines exist to support practice. We performed an …

Simple Summary Currently, Stereotactic Body Radiation Therapy (SBRT) is reserved for
head and neck cancer (HNC) patients who are not suitable candidates for conventional …

Background and purpose Although reirradiation has attracted attention as a potential
therapy for recurrent head and neck tumors with the advent of modern radiotherapy, severe …